SLSilas Lagat

Silas Lagat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Silas Lagat has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sorption Mechanisms and Enhancement of Selected Organochlorine Pollutants in Water on Zeolites

    by Timothy Manda, Solomon Omwoma, Godfrey Okumu Barasa, Anthony M. Pembere, Douglas Sifuna, Livingstone Ochilo, Silas Lagat, Emily Ngeno, Patrick Ssebugere, Christine Betty Nagawa, et al.

    This study investigates the adsorption capacities of selected organochlorines on zeolites, focusing on hexachlorobenzene (HCB), hexachlorotetradecane (HCTD), hexachlorodecane (HCD), hexachlorocyclohexane (HCH), heptachlorodecane (HPCD), octachlorodecane (OCD), dichlorodiphenyltrichloroethane (DDT), and octachlorotetradecane (OCTD). The structures of the organochlorines were optimized and their Frontier molecular orbitals were calculated. The analysis of HOMO (highest occupied molecular orbital) and LUMO (lowest unoccupied molecular orbital) energies provided insights into the molecules’ electron-donating and -accepting capabilities. The present research identified the universal force field as suitable for the investigation and used it to evaluate the adsorption capacities of the pollutants on various zeolites. It was found that CLO (a cubic microporous gallophosphate) demonstrated the highest adsorption capacity for HCB among 245 zeolites, with a loading capacity of 65.84 wt%. In terms of molecules adsorbed per cell, CLO remained the highest with 120 molecules per cell for HCB, 113 molecules per cell for HCH, 43 molecules per cell for DDT, 21 molecules per cell for HCTD, 19 molecules per cell for OCTD, 47 molecules per cell for HCD, 30 molecules per cell for HPCD, and 22 molecules per cell for OCD. The analysis revealed correlations between the structural parameters of zeolites (mass, density, HVF, APV, VSA, GSA, DPS, and Di) and their adsorption capacities. The investigation delved into cluster models to understand the interaction of organochlorines with the zeolite framework. The study explored the impact of doping CLO zeolite with different atoms (Al, Si, and Na) on adsorption capacity. The results showed that doping with aluminum improved both loading capacity and adsorption energy and dissociate the chlorinated compounds during adsorption. Quantum chemical calculations show that hydrogen-based bonding of the organochlorides on the CLO is thermodynamically favorable compared to dissociative adsorption. In addition, oxygen atoms in the zeolites provide active adsorption sites. In the present work, laboratory adsorption experiments were performed, treating zeolites with heat at 400°C. Surprisingly, untreated zeolites outperformed treated ones, adsorbing up to 91% of HCB, while treated zeolites reached saturation after the third run. The study attributed the better performance of untreated zeolites to the presence of interstitial water and hydrogen atoms, which are critical for electrostatic interactions with organic compounds. In general, this research provides a comprehensive analysis of the adsorption capacities of organochlorines on zeolites, combining computational simulations and laboratory experiments. This work’s distinctive quality is its methodology that combines molecular simulations, experimental verification, doping, and interstitial water effects. The findings emphasize the importance of zeolite (a high-porosity nanostructured material) structure, composition, and treatment methods in determining their effectiveness as adsorbents for environmental pollutants.


  • Open Access

    Synthesis and Characterization of Activated Carbon from Agrowastes for the Removal of Acetic Acid from an Aqueous Solution

    by Joel Brian Njewa, Timothy Tiwonge Biswick, Ephraim Vunain, Cheruiyot Silas Lagat, Solomon Omwoma Lugasi

    In this study, activated carbons prepared from agrowastes by chemical activation were used to remove acetic acid from an aqueous solution through a batch process. The prepared adsorbents were characterized by SEM, XRD, FT-IR, and point of zero charge (pHpzc). The effects of adsorbent dosage, initial concentration, and contact time were considered. Equilibrium data was tested using Langmuir, Freundlich, Temkin, and Frenkel–Halsey–Hill models. The degree of adsorption of acetic acid increased for both adsorbents as contact time, and adsorbent dosage and initial concentration were increased. The adsorption data were described well by the (Freundlich=Frenkel–Halsey–Hill) models with the highest regression coefficient of and for Rice Husk Activated Carbon (RH-AC) and Potato Peels Activated Carbon (PP-AC), respectively. This suggests a multilayer through the existence of a heterogeneous pore distribution in the adsorbent surface. Kinetic data agreed well with pseudosecond-order ( and ) RH-AC and PP-AC, correspondingly. This indicates that the adsorption process was chemisorption in nature. The regeneration studies showed that the adsorbents prepared could be renewed and reused before losing their adsorbing affinity for acetic acid.


  • Open Access

    Adapting the HIV Infant Tracking System to Support Prevention of Mother-to-Child Transmission of HIV in Kenya: Protocol for an Intervention Development Pilot Study in Two Hospitals

    by Sarah Finocchario-Kessler, May Maloba, Melinda Brown, Brad Gautney, Kathy Goggin, Catherine Wexler, Natabhona Mabachi, Beryne Odeny, Silas Lagat, Sharon Koech, et al.

    Background: Despite progress to expand access to HIV testing and treatment during pregnancy in Kenya, gaps still remain in prevention of mother-to-child transmission of HIV (PMTCT) services. This study addresses the need for effective and scalable interventions to support women throughout the continuum of care for PMTCT services in low-resource settings. Our research team has successfully implemented the HIV Infant Tracking System (HITSystem), a Web-based, system-level intervention to improve early infant diagnosis (EID) outcomes. Objective: This study will expand the scope of the HITSystem to address PMTCT services to bridge the gap between maternal and pediatric HIV services and improve outcomes. This paper describes the intervention development protocol to adapt and pilot an HITSystem version 2.0 to assess acceptability, feasibility, and preliminary PMTCT outcomes in Kenya. Methods: This is a 3-year intervention development study to adapt the current HITSystem intervention to support a range of PMTCT outcomes including appointment attendance, antiretroviral therapy (ART) adherence, hospital deliveries, and integration of maternal and pediatric HIV services in low-resource settings. The study will be conducted in 3 phases. Phase 1 will elicit feedback from intervention users (patients and providers) to guide development and refinement of the new PMTCT components and inform optimal implementation. In Phase 2, we will design and develop the HITSystem 2.0 features to support key PMTCT outcomes guided by clinical content experts and findings from Phase 1. Phase 3 will assess complete PMTCT retention (before, during, and after delivery) using a matched randomized pilot study design in 2 hospitals over 18 months. A total of N=108 HIV-positive pregnant women (n=54 per site) will be enrolled and followed from their first PMTCT appointment until infant HIV DNA Polymerase Chain Reaction testing at the target age of 6 weeks (<7 weeks) postnatal. Results: Funding for this study was received in August 2015, enrollment in Phase 1 began in March 2016, and completion of data collection is expected by May 2019. Conclusions: This protocol will extend, adapt, and pilot an HITSystem 2.0 version to improve attendance of PMTCT appointments, increase ART adherence and hospital-based deliveries, and prompt EID by 6 weeks postnatal. The HITSystem 2.0 aims to improve the integration of maternal and pediatric HIV services. Trial Registration: ClinicalTrials.gov NCT02726607; https://clinicaltrials.gov/ct2/show/NCT02726607 (Archived by WebCite at http://www.webcitation.org/78VraLrOb) International Registered Report Identifier (IRRID): DERR1-10.2196/13268